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   UTILIZATION OF BROMINATION REACTION 
FOR THE SPECTROPHOTOMETRIC ASSAY 
OF DOMPERIDONE IN PHARMACEUTICALS 
Three simple and sensitive spectrophotometric methods are described for the 
determination of domperidone (DOM) in bulk drug and in dosage forms using 
bromate-bromide mixture as brominating agent in acid medium and three dyes, 
meta-cresol purple (MCP), amaranth (AMR) and erioglaucine (EGC). The me-
thods involve the addition of a known excess of bromate-bromide mixture to an 
acidified solution of DOM followed by the determination of the residual bromine 
by reacting with a fixed amount of either MCP dye and measuring the absor-
bance at 530 nm (method A) or AMR dye and measuring the absorbance at 
520 nm (method B) or EGC dye and measuring the absorbance at 630 nm 
(method C). Beer’s law is obeyed over the concentration ranges, 0.63–10.0, 
0.25-4.0 and 0.13-2.0 µg mL
-1 for method A, B and C, respectively. The ap-
parent molar absorptivities are calculated to be 3.751×10
4, 6.604×10
4 and 
1.987×10
5 L mol
-1cm
-1 for method A, B and C, respectively, and the corres-
ponding sandell sensitivity values are 0.011, 0.006 and 0.002 μg cm
-2. The 
limit of detection and the limit of quantification are also reported for all the three 
methods. No interference was observed from common additives found in phar-
maceutical preparations. Statistical comparisons of the results with those of 
the reference method showed excellent agreement, and indicated no signifi-
cant difference in accuracy and precision. The accuracy and reliability of the 
methods were further ascertained by performing recovery tests via standard-
-addition technique. 
Key words: domperidon; assay; spectrophotometry; bromate-bromide; dyes; 
tablets. 
 
 
Domperidone (DOM), 5-chloro-1-[1-[3-(2-oxo- 
-2,3-dihydro-1H-benzimidazole-1-yl)propyl]piperidin-4- 
-yl]-1, 3-dihydro-2H-benzimidazol-2-one (Figure 1), is 
used as an anti-emetic and to suppress nausea and 
vomiting. DOM is indicated for treating symptoms as-
sociated with upper gastrointestinal motility disorders 
caused by chronic and sub-acute gastritis. It is a gas-
trointestinal emptying (delayed) adjuvant, a peristaltic 
stimulant and exhibits antiemetic properties. It can be 
used in patients with Parkinson’s disease [1] and is 
also found to be effective in the treatment of gastro-
paresis [2]. It is official in BP [3] which recommends 
non-aqueous titration with perchloric acid as titrant 
and naphtholbenzein as indicator. 
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Figure 1. Structure of domperidone. 
Several methods have been reported for the de-
termination of domperidone in pharmaceuticals, inc-
luding differential pulse voltammetry [4], anodic diffe-
rence pulse voltammetry [5], potentiometry [6], planar 
chromatography [7], high-performance liquid chroma-
tography [8-19] and high-performance thin-layer chro-
matography [20-25]. Many of these techniques are 
deficient in simplicity, cost-effectiveness and easy ac-
cessibility. 
Spectrophotometry is characterized by its speed 
and simplicity, accuracy and inexpensive instrument 
needed, and hence it is an important alternative to 
other analytical techniques with clear advantages in O.Z. DEVI, K. BASAVAIAH, K.B. VINAY: UTILIZATION OF BROMINATION REACTION…  CI&CEQ 17 (1) 81−89 (2011) 
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terms of cost of analysis. Rajendraprasad et al. [26] 
have described a UV-spectrophotometric method (λmax =  
= 284 nm) for DOM in pharmaceuticals. There is only 
one report on the visible spectrophotometric assay of 
DOM in pharmaceuticals [27] in which four proce-
dures are described. The first two methods are based 
on redox-complexation reactions involving Fe
3+, o-phe-
nanthroline and bipyridyl [27] and the other two me-
thods utilized cerium(IV) as the oxidimetric reagent, 
which was subsequently determined by decrease of 
red color of chromotrope 2R or orange pink color of 
Rhodamine 6G [27]. 
The reported four visible spectrophotometric me-
thods [27] involve a heating step and the procedures 
based on redox-complexation reactions require strict 
pH control. The present communication reports three 
simple and sensitive spectrophotometric methods for 
the assay of DOM in bulk drug and in tablets based 
on bromination of DOM by in situ generated bromine. 
The proposed methods have the advantages of speed, 
free from stringent experimental conditions like heat-
ing step and pH adjustment, besides being accurate 
and precise. In addition to these, the highlight of the 
present investigation is the use of cheap and eco- 
-friendly green brominating agent i.e. bromate-bromi-
de mixture and avoidance of corrosive liquid bromine. 
This is one step towards green chemistry. 
EXPERIMENTAL DETAILS 
Apparatus. All absorbance measurements were 
made on a Systronics model 106 digital spectropho-
tometer (Ahmedabad, India) provided with 1-cm ma-
tched quartz cells. 
Materials and reagents. All chemicals and rea-
gents used were of analytical or pharmaceutical gra-
de. Distilled water was used to prepare the solutions.  
Bromate-bromide mixture (200, 40 and 12 μg 
mL
-1). A stock standard solution of bromate-bromide 
mixture equivalent to 1000 µg mL
-1 KBrO3 containing 
an excess KBr was prepared by dissolving accurately 
weighed 100 mg of KBrO3 (S. D. Fine Chem. Ltd., 
Mumbai, India) and 1 g of KBr (Merck, Mumbai, India) 
in water and diluting to 100 mL in a calibrated flask. 
The stock solution was diluted stepwise to obtain 40, 
200 and 12 µg mL
-1 solutions with respect to KBrO3 
for use in methods A, B and C, respectively.  
Meta cresol purple solution (80 μg mL
-1). A 400 
µg mL
-1 stock solution was first prepared by dissolving 
40 mg of dye (Loba Chemie, Mumbai, India) in 2 mL 
of 0.1 N NaOH and diluted to volume with water in a 
100 mL calibrated flask, and was diluted further to get 
a working concentration of 80 μg mL
-1 dye solution.  
Amaranth solution (200 µg mL
-1).  The solution 
was prepared by dissolving 24 mg of dye (S. D. Fine 
Chem. Ltd., Mumbai, India; dye content 85%) in water 
and diluting to 100 mL with water in a calibrated flask. 
Erioglaucine solution (200 μg mL
-1). The solution 
was prepared by dissolving 20 mg of dye (Loba Che-
mie, Mumbai, India) in water and diluting to 100 mL 
with water in a calibrated flask. 
Hydrochloric acids (10, 5, 2 and 1 M). The so-
lutions were prepared by appropriate dilution of con-
centrated acid (S. D. Fine Chem. Ltd., Mumbai, India; 
Sp. gr. 1.18) with water. 
Standard DOM solution.  Pharmaceutical grade 
DOM certified to be 99.85% was kindly provided by 
Cipla India Ltd., Mumbai, India, and was used as re-
ceived. A stock standard solution of 500 µg mL
-1 DOM 
was first prepared by dissolving 50 mg of pure drug in 
100 mL of 3:7 dilute acetic acid (acetic acid:water), 
and was further diluted stepwise with the same acid 
to get 25, 10 and 5 μg mL
-1 DOM for methods A, B 
and C, respectively. 
Two brands of tablets containing DOM, Doms-
tal-10 (Torrent Pharmaceuticals Ltd., M.P., India) and 
Vemistop-10 (Cipla Ltd., H.P., India) used in the in-
vestigation were purchased from local commercial 
sources. 
Sample preparation 
Tablets.  Ten tablets were accurately weighed 
and powdered. A portion equivalent to 25 mg was 
transferred into a 50 mL calibrated flask, 30 mL of 3:7 
dilute acetic acid (acetic acid:water) was added to the 
flask and the content was shaken thoroughly for 15-
20 min to extract the drug into the liquid phase; the 
volume was finally diluted to the mark with the same 
acid (50 mL flask), mixed well and filtered using a 
Whatman No. 42 filter paper. The filtrate equivalent to 
500 μg mL
-1 was further diluted with the same acid to 
get 25, 10 and 5 μg mL
-1 for methods A, B and C, 
respectively. 
Placebo blank. A placebo blank of the com-
position: talc (43 mg), starch (35 mg), acacia (25 mg), 
methyl cellulose (40 mg), sodium citrate (25 mg), ma-
gnesium stearate (35 mg) and sodium alginate (30 
mg) was made and its solution was prepared in 25 mL 
calibration flask as described under “Procedure for 
tablets“. 
Synthetic mixture. To the placebo blank of the 
composition described above, 25 mg of DOM was ad-
ded and homogenized, transferred to a 50 mL calibra-
ted flask and the solution was prepared as described 
under “Procedure for tablets”. O.Z. DEVI, K. BASAVAIAH, K.B. VINAY: UTILIZATION OF BROMINATION REACTION…  CI&CEQ 17 (1) 81−89 (2011) 
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General procedures 
Method A (using MCP). Different aliquots (0.25, 
0.5, 1.0, 2.0, 3.0 and 4.0 mL) of 25 μg mL
-1 DOM 
solution were accurately transferred into a series of 
10 mL calibrated flasks using micro burette and the 
total volume was adjusted to 4.0 mL by adding 3:7 
acetic acid. To each flask were added 1 mL each of 
10 M HCl and bromate-bromide (40 μg mL
-1 w.r.t 
KBrO3). The flasks were stoppered, the content was 
mixed well and the flasks were let to stand for 15 min 
with occasional shaking. Then, 1 mL of 80 μg mL
-1 
MCP was added to each flask by means of micro 
burette, diluted to the mark with water, mixed and 
absorbance of each solution was measured at 530 
nm against a reagent blank. 
Method B (using AMR). Varying aliquots (0.25, 
0.5, 1.0, 2.0, 3.0 and 4.0 mL) of DOM solution (10 
μg/mL
–1) were accurately measured into a series of 10 
mL calibrated flasks by means of micro burette and 
the total volume was brought to 4 mL by adding 3:7 
acetic acid. To each flask were added 1 mL of 5M HCl 
followed by 1 mL of KBrO3-KBr solution (200 μg mL
-1 
w.r.t. KBrO3). The flasks were stoppered immediately, 
content mixed, and kept aside for 10 min with occa-
sional shaking. Lastly, 1 mL of 200 μg mL
-1 AMR so-
lution was added to each flask and diluting up to the 
mark with water. The absorbance of each solution 
was measured at 520 nm against reagent blank. 
Method C (using EGC). Different aliquots (0.25, 
0.5, 1.0, 2.0, 3.0 and 4.0 mL) of standard DOM so-
lution (5 µg mL
-1) were transferred into a series of 10 
mL standard calibrated flasks and the total volume in 
each flask was adjusted to 4 mL with
 3:7 acetic acid. 
Added to each flask were 1 mL of 1 M HCl and 1 mL 
of bromate-bromide (12 μg mL
-1 w.r.t KBrO3). The 
flasks were stoppered, the content was mixed and the 
flasks were let stand for 10 min with occasional shak-
ing. Then, 1 mL of 2 M HCl and 1 mL 200 μg mL
-1 
EGC were added to each flask by means of micro 
burette, diluted to the mark with water, mixed and ab-
sorbance of each solution was measured at 630 nm 
against a reagent blank after 5 min. 
RESULTS AND DISCUSSION 
The bromate-bromide mixture with a number of 
dyes like methyl orange, indigo carmine, methylene 
blue, rhodamine-B, meta cresol purple etc. has suc-
cessfully been employed for the assay of several 
pharmaceuticals [28-31]. From the preliminary experi-
ments, DOM was found to undergo bromination by 
bromine, generated in situ by the action of acid on 
bromate-bromide mixture and the dyes, meta cresol 
purple, amaranth and erioglaucine were found to un-
dergo bleaching in acid medium by bromine. Based 
on this observation, three indirect spectrophotometric 
methods using bromate-bromide mixture and three 
dyes, meta-cresol purple (MCP), amaranth (AMR) and 
erioglaucine (EGC) were developed. The proposed 
methods are based on the bromination of DOM by a 
measured excess of in situ bromine followed by the 
determination of the residual bromine by reacting it 
with the cited dyes. The amount of bromine reacted 
corresponds to the amount of drug initially present. 
The pink color of MCP and AMR in acid medium 
exhibited strong absorbtion maxima at 530 and 520 
nm, respectively, and the green color of EGC dye in 
acid medium absorbs maximally at 630 nm (Figure 2). 
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Figure 2. Absorption spectra (5 μg mL
-1 DOM in method A, 3 μg mL
-1 DOM in method B and 1 μg mL
-1 DOM in method C). O.Z. DEVI, K. BASAVAIAH, K.B. VINAY: UTILIZATION OF BROMINATION REACTION…  CI&CEQ 17 (1) 81−89 (2011) 
 
84 
DOM when added in increasing concentrations 
to a fixed concentration of in situ generated bromine, 
consumes the latter proportionately and there occurs 
a concomitant fall in the concentration of bromine. 
When a fixed concentration of either dye was added 
to the decreasing concentrations of bromine, a conco-
mitant increase in the concentration of dye resulted. 
This was observed as a proportional increase in the 
absorbance at the respective λmax with increasing 
concentration of DOM. 
Chemistry 
Since DOM contains aromatic amines, it under-
goes an electrophilic aromatic substitution reaction 
with  in situ generated bromine. Nitrogen atoms at-
tached to the benzene ring are ortho- and para-direc-
tors [32] but the bromination of DOM occurs at the 
para-positions only due to the steric effect of the 
amide which leads to a decrease in the amount of the 
ortho-product. 
Hydroxy substituents activate the benzene ring 
and direct the electrophile towards ortho- and para-
positions, whereas the sulphonate substituent deacti-
vates the benzene ring and directs the electrophile to-
wards meta-position [32]. Hence, bromination of the 
dyes, meta cresol purple (MCP), amaranth (AMR) and 
erioglaucine (EGC) with the unreacted bromine oc-
curs either at ortho- and para- positions to the –OH 
groups or meta to the sulphonate group or ortho- and 
para- to the nitrogen atom. In all the methods, bleach-
ing occurs because of the bromination of the dyes. 
The probable reaction mechanisms are shown in Fi-
gure 3. 
Optimization of variables 
Preliminary experiments were performed to de-
termine the concentration of each dye; producing a 
reasonably high absorbance; and these were found to 
be 8, 20 and 20 μg mL
-1 for MCP, AMR and EGC, 
respectively. The KBrO3 concentration (in the presen-
ce of excess KBr) required to bleach the dyes com-
pletely in acid medium was also determined and found 
to be 4 μg mL
-1 for MCP, 20 μg mL
-1 for AMR and 1.2 
μg mL
-1 for EGC. Hence, different concentrations of 
DOM were reacted with 1.0 mL each of 40 μg mL
-1 
KBrO3 in method A, 200 μg mL
-1 KBrO3 in method B 
and 12 μg mL
-1 KBrO3 in method C, before determin-
ing the residual bromine as described under the res-
pective procedures. Hydrochloric acid was the ideal 
medium for bromination reaction as well as the deter-
mination of residual bromine by using any of the stu-
died dyes. In method A, the reaction between DOM 
and bromine (in situ) was unaffected when 1.5-3.0 mL 
of 5 M HCl was used (Figure 4). Hence, 1 mL of 10 M 
HCl equivalent to 2 mL of 5 M HCl was used for both 
steps of the reaction. In method B, since (0.5-3.0) mL 
of 5 M HCl gave constant absorbance readings (Fi-
gure 4), 1 mL of 5 M HCl was used for both steps of 
the reaction. However, in method C, bromination of 
DOM was found to be faster in lower acid concen-
tration and bleaching of EGC by bromine required 
higher concentration of acid. For the bromination 
step, 1 mL of 1 M HCl was used, since (0.5-2.0) mL of 
1 M HCl gave constant absorbance readings (Figure 
5), and for the bleaching step further addition of 1 mL 
of 2 M HCl was necessary. At lower acid concentra-
tions, bleaching of dye took a longer time. For quan-
titative reaction between DOM and bromine (in situ), a 
contact time of 15 min was found sufficient in method 
A and 10 min in both methods B and C and constant 
absorbance readings were obtained when contact ti-
mes were extended up to 30 min in all the methods 
(Figure 6). The bleaching of the dyes was found to be 
instantaneous in methods A and B, while 5 min was 
required in method C. 
Method validation 
The proposed methods have been validated for 
linearity, sensitivity, precision, accuracy, robustness, 
ruggedness, selectivity and recovery according to the 
International Conference on Harmonization (ICH) [33]
 
guidelines. 
Linearity and sensitivity. Under optimum condi-
tions a linear relation was obtained between absor-
bance and concentration of DOM in the range of 0.63- 
–10.0 μg mL
-1 (method A), 0.25-4.0 μg mL
-1 (method 
B) and 0.13-2.0 μg mL
-1 (method C). The linear plots 
gave the following regression equations: 
y = 0.010 + 0.086x for method A, 
y = 0.020 + 0.164x for method B and  
y = 0.008 + 0.452x for method C 
where  y = absorbance and x = concentration in 
μg mL
-1) obtained by the method of least squares. 
The correlation coefficient, intercept and slope for the 
calibration data are summarized in Table 1. Sensiti-
vity parameters such as apparent molar absorptivity 
and sandell sensitivity values, the limit of detection 
(LOD) and the limit of quantification (LOQ) are calcul-
ated as per the current ICH guidelines [33] are com-
piled in Table 1 speak of the excellent sensitivity of 
the proposed method. LOD and LOQ were calculated 
according to the same guidelines using the formulae: 
LOD = 3.3σ/s and LOQ = 10σ/s 
where σ is the standard deviation of five reagent blank 
determinations and s is the slope of the calibration 
curve. O.Z. DEVI, K. BASAVAIAH, K.B. VINAY: UTILIZATION OF BROMINATION REACTION…  CI&CEQ 17 (1) 81−89 (2011) 
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Precision and accuracy. Intra-day precision and 
accuracy of the proposed methods were evaluated by 
replicate analysis (n = 7) of calibration standards at 
three different concentration levels in the same day. 
Inter-day precision and accuracy were determined by 
assaying the calibration standards at the same con-
centration levels on five consecutive days. Precision 
and accuracy were based on the calculated relative 
standard deviation (RSD / %) and relative error (RE / %) 
of the found concentration compared to the theore-
tical one, respectively (Table 2). 
Robustness and ruggedness. Method robustness 
was tested by making small incremental change in 
HCl concentration and reaction time in all the me-
thods. To check the ruggedness, analysis was per-
formed by four different analysts, and on three diffe-
rent spectrophotometers by the same analyst. The 
robustness and the ruggedness were checked at three 
different drug levels. The intermediate precision, ex-
pressed as percent RSD, which is a measure of ro-
bustness and ruggedness was within the acceptable 
limits as shown in Table 3. 
N
N
H
O
N
N
H
N
Cl
O
N
N
H
O
Br
Br
N
N
H
N
Cl
O
Br
O
S
O O
OH
OH
O
S
O O
OH
OH
Br
Br
Br Br
Br
Br
N S
N
O
O
-O
O H S
S
O
O
O
O
O-
O-
N S
N
O
O
-O
O H S
S
O
O
O
O
O-
O-
Br
Br
S
N
+ S
O
O
O
O
O
O
N
S
O
O
O
S Br
Br
N
+ S
O
O
O
O
N
S
O
O
O
Br Br
O
O
Br
Br
+ Known excess of Br2 + 3HBr + unreacted Br2
unreacted Br2
+ 
+ 6HBr
(pink color which absorbs 
    maximum at 530 nm)
colorless bromination product of MCP
DOM Bromination product of DOM
BrO3
- + 5Br- + 6H+ 3Br2 + 3H2O
MCP
Method A
unreacted Br2 + 
+ 2HBr
                AMR
(pink color which absorbs 
maximum at 520 nm)
colorless bromination product of AMR
Method B
unreacted Br2 + 
H+
                 EGC
(green color which absorbs 
maximum at 630 nm)
colorless bromination product of EGC
+ 6HBr
Method C  
Figure 3. Probable reaction scheme. O.Z. DEVI, K. BASAVAIAH, K.B. VINAY: UTILIZATION OF BROMINATION REACTION…  CI&CEQ 17 (1) 81−89 (2011) 
 
86 
0.5 1.0 1.5 2.0 2.5 3.0
0.30
0.32
0.34
0.36
0.38
0.40
0.42
0.44
0.46
0.48
0.50
0.52
0.54
0.56
0.58
0.60
A
b
s
o
r
b
a
n
c
e
Volume of HCl (5 M)
 Method A
 Method B
 
Figure 4. Effect of HCL in methods A and B (5 μg mL
-1 DOM in 
method A and 3 μg mL
-1 DOM in method B). 
0.5 1.0 1.5 2.0 2.5 3.0
0.25
0.30
0.35
0.40
0.45
A
b
s
o
r
b
a
n
c
e
Volume of HCl (1 M)  
Figure 5. Effect of HCL (1 μg mL
-1 DOM) in method C. 
5 1 01 52 02 53 0
0.30
0.32
0.34
0.36
0.38
0.40
0.42
0.44
0.46
0.48
0.50
0.52
0.54
0.56
A
b
s
o
r
b
a
n
c
e
Reaction time, min
 Method A
 Method B
 Method C
 
Figure 6. Effect of reaction time (5 μg mL
-1 DOM in method A, 
3 μg mL
-1 DOM in method B and 1 μg mL
-1 DOM in method C). 
Selectivity. The proposed methods were tested 
for selectivity by placebo blank and synthetic mixture 
analyses. A convenient aliquot of the placebo blank 
solution was subjected to analysis according to the 
recommended procedures. In all the cases, there was 
no interference by the inactive ingredients. 
Table 1. Sensitivity and regression parameters 
Parameter 
Method 
A B C 
λmax / nm  530  520  630 
Linear range, μg mL
-1 0.63-10.0  0.25-4.0
  0.13-2.0
 
Molar absorptivity (ε), L mol
-1 cm
-1 3.75×10
4 6.60×10
4 1.99×10
5
Sandell sensitivity
a, μg cm
-2 0.011  0.006  0.002 
LOD / μg mL
-1 0.07  0.04  0.00 
LOQ / μg mL
-1 0.21  0.13  0.01 
Regression equation, y
b 
Intercept (a) 0.010  0.020  0.008 
Slope (b) 0.086  0.164  0.452 
Standard deviation of a (Sa) 0.047  0.126  0.037 
Standard deviation of b (Sb) 0.005  0.036  0.020 
Regression coefficient (r) 0.997  0.997  0.999 
a
Limit of determination as the weight in μg per mL of solution, which cor-
responds to an absorbance of A = 0.001 measured in a cuvette of cross- 
-sectional area 1 cm
2 and l = 1 cm; 
by = a + bX, Where y is the absor-
bance, x is concentration in μg mL
-1, a is intercept, b is slope 
A separate experiment was performed with the 
synthetic mixture. The analysis of synthetic mixture 
solution yielded percent recoveries which ranged 
97.58-104.3% with standard deviation of 1.62–2.41% 
in all the cases. The results of this study, presented in 
Table 4, indicate that the inactive ingredients did not 
interfere in the assay. These results further demons-
trate the accuracy as well as the precision of the pro-
posed methods. 
Application to assay in tablets 
In order to evaluate the analytical applicability of 
the proposed methods to the quantification of DOM in 
commercial tablets, the results obtained by the pro-
posed methods were compared to those of the refe-
rence method [3] by applying Student’s t-test for accu-
racy and F-test for precision. The results (Table 5) 
show that the Student’s t- and F-values at 95% confi-
dence level are less than the theoretical values, which 
confirmed that there is a good agreement between 
the results obtained by the proposed methods and the 
reference method with respect to accuracy and pre-
cision. 
Recovery studies. The accuracy and validity of 
the proposed methods were further ascertained by 
performing recovery studies. Pre-analysed tablet pow-
der was spiked with pure DOM at three concentration 
levels (50, 100 and 150% of that in tablet powder) and 
the total was found by the proposed methods. In all 
cases, the added DOM recovery percentage values  O.Z. DEVI, K. BASAVAIAH, K.B. VINAY: UTILIZATION OF BROMINATION REACTION…  CI&CEQ 17 (1) 81−89 (2011) 
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ranged 105.56-112.3% with standard deviation of 
1.51-2.14% (Table 6) indicating that the recovery was 
good, and that the co formulated substance did not 
interfere in the determination. 
CONCLUSIONS 
Three rapid, relatively specific, accurate and pre-
cise spectrophotometric methods for the determina-
tion of DOM in pure form and in tablets were de-
veloped and validated as per as the current ICH gui-
delines. Compared with most of the existing methods 
for DOM, the present methods are very simple and 
cost effective. Of the non-chromatographic methods, 
the methods based on voltammetric [4,5] and poten-
tiometric sensor [6] techniques involve rigid pH con-
trol. The chromatographic techniques [7-25] although 
Table 2. Evaluation of intra-day and inter-day accuracy and precision (RE: relative error; RSD: relative standard deviation) 
Method
  DOM taken 
μg mL
-1 
Intra-day accuracy and precision (n = 7)  Inter-day accuracy and precision (n = 7) 
DOM found, μg mL
-1 RE / %  RSD / %  DOM found, μg mL
-1  RE / %  RSD / % 
Method A (using MCP)  2.5  2.44  2.40  2.41  2.43  2.80  2.37 
5.0  5.13 2.61  2.27 5.15 3.00  2.31 
7.5  7.68 2.46  1.21 7.71 2.80  2.05 
Method B (using AMR)  2.0  1.96  2.00  0.57  1.94  3.00  3.13 
3.0  3.05 1.67  1.76 2.93 2.33  2.97 
4.0  3.90 2.50  0.89 4.11 2.75  3.19 
Method C (using EGC)  0.5  0.486  2.80  2.07  0.485  3.00  2.11 
1.0 1.02  2.00  1.41  0.971  2.87  2.78 
1.5 1.54  2.67  1.93  1.459  2.73  2.16 
Table 3. Robustness and ruggedness expressed as intermediate precision (%RSD) 
Method 
DOM taken
μg mL
-1 
Method robustness 
Method ruggedness 
Parameter altered 
HCl, mL
a; RSD
b, % () (n = 3) 
Reaction time
c, min;
RSD, % (n = 3) 
Inter-analysists’ RSD, % 
(n = 4) 
Inter-instruments’
RSD, % (n = 3) 
Method A (using MCP)  2.5  1.57  2.07  1.18  3.36 
5.0 1.35  1.68 1.09  3.29 
7.5 1.43  1.74 1.02  3.32 
Method B (using AMR)  2.0  1.23  1.64  1.06  2.41 
3.0 1.19  1.41 0.97  2.26 
4.0 1.31  1.95 1.12  2.35 
Method C (using EGC)  0.5  1.25  1.32  1.01  3.39 
1.0 1.16  1.27 1.13  4.28 
1.5 1.19  1.25 1.05  4.31 
a
HCl volumes used were 0.8, 1.0 and 1.2 mL in all the three methods; 
b10 M in method A, 5 M in method B and 1 M in method C;
 creaction times altered 
were 13, 15 and 17 min in method A and 8, 10 and 12 min in both methods B and C 
Table 4. Recovery of the drug from synthetic mixture 
Method  DOM in synthetic mixture taken, μg mL
-1  DOM recoverd
a±SD, % 
Method A (using MCP)  2.5  102.5±2.27 
5.0 104.3±1.77 
7.5 103.2±2.41 
Method B (using AMR)  1.0  98.50±1.62 
2.0 97.58±1.84 
3.0 99.21±2.10 
Method C (using EGC)  0.5  102.9±1.93 
1.0 103.1±1.64 
1.5 102.4±1.87 
a
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sensitive, require expensive instrumental-set up. A large 
volume of solvents is required for these techniques, 
which are expensive, hazardous to health, and harm-
ful to the environment. HPLC requires precolumn de-
rivatization without preliminary separation. It requires 
either an organic solvent extraction or use of surfac-
tants and alcohols in the mobile phase. The reported 
four visible spectrophotometric methods [27] require 
boiling for 5-10 min and in addition to this, the proce-
dures based on redox-complexation reaction also re-
quire strict pH control. 
In contrast to the above published methods, the 
present methods are free from unwelcome steps such 
as heating or extraction and also from critical pH con-
ditions. The methods are also useful due to high tole-
rance limit for common excipients found in drug for-
mulations. These merits coupled with the use of simp-
le and eco-friendly green brominating agent and avoid-
ance of use of corrosive liquid bromine, the present 
investigation represents relatively green procedures.  
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NAUČNI RAD 
   SPEKTROFOTOMETRIJSKO ODREĐIVANJE 
DOMPERIDONA U FARMACEUTSKIM 
PREPARATIMA PRIMENOM REAKCIJE 
OKSIDACIJE BROMATA 
U radu su opisane tri jednostavne i osetljive spektrofotometrijske metode za određivanje 
domperidona (DOM), u rasutom stanju i u formi lekova korišćenjem smeše bromata i 
brimida, kao reagensa za bromovanje u kiseloj sredini, i tri boje, ljubičasti meta-krezol 
(MCP), amarant (AMR) i erioglaucin (EGC). Metode se zasnivaju na dodavanju 
poznatog viška smeše bromata i bromida zakišeljenom rastvoru DOM-a i određivanju 
rezidualnog broma reakcijom sa određenom količinom boje. Talasne dužina određivanja 
sa bojama MCP (metoda A), AMR (metoda B) i EGC (metoda C) su 530, 520 i 630 nm, 
respektivno. Odeđivanja su u skladu sa Beer-ovim zakonom u opsegu koncentracijska 
od 0,63-10,0, 0,25-4,0 i 0,13-2,0 µg mL
-1 za metode A, B i C, redom. Izračunate molarne 
apsorptivnosti iznose: 3.751×10
4, 6.604×10
4 and 1.987×10
5 L mol
-1 cm
-1 za metode A, B i 
C, redom, a odgovarajući Sandell-ovi indeksi su: 0,011, 0,006 i 0,002 μg cm
-2. Limiti de-
tekcije i limiti kvantifikacije su, takođe, određeni za sve tri metode. Nije zapažena inter-
ferencija sa uobićajenim aditivima koji se nalaze u farmaceutskim preparatima. Statistič-
ka poređenja rezultata sa onima u referentnoj metodi pokazala su odlična slaganja, što 
je ukazalo da nema značajne razlike u tačnosti i preciznosti između metoda. Tačnost i 
pouzdanost metode su dodatno potvrđeni određivanjem procenta prinosa (recovery 
vrednosti) metodom standardnog dodataka. 
Ključne reči: domperidon; određivanje; spektrofotometrija; bromat-bromid; boje;  
tablete. 
 
 